Clinical
features
Investigations
Therapy
Prevention
Prognosis
|  |  | | Prevention |
Ventricular arrhythmias
Consider adding one of the following:
-
amiodarone
b
-
metoprolol a
-
sotalol a
Why?
-
Patients on amiodarone have fewer shocks than patients on other anti-arrhythmics
b
-
Patients on sotalol have fewer shocks than on placebo, but there is no clear effect on mortality
a
- Metoprolol is more effective than sotalol at preventing shocks, but there is no clear effect on mortality
a
Metoprolol is more effective than sotalol at reducing shocks from implanted defibrillators
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRR (95% CI) |
NNT
(95% CI) |
implantable defibrillator for VT
a
|
sotalol
|
placebo
|
defibrillator shock
at 12
months
|
48%
|
38%
(17% to 54%)
|
5
(3 to 13)
|
implantable defibrillator for VT
a
|
sotalol
|
metoprolol
|
defibrillator shock
|
20%
|
-140%
(-410% to -15%)
|
-4
(-14 to -20)
|
|